A review of pivotal clinical trials for semaglutide (STEP, SUSTAIN), dulaglutide (REWIND), liraglutide (LEADER), and tirzepatide (SURPASS, SURMOUNT) does not identify muscle cramps as occurring at significantly higher rates compared to placebo groups
However, adherence to specific dietary modifications, such as reducing portion sizes, limiting dietary fat and poorly digestible fibres, spacing meals, and ensuring adequate hydration, has proven effective in mitigating these side effects
6 min read How to Inject Semaglutide - Step-by-Step Guide for Safe & Effective Use Semaglutide injections have revolutionized the treatment for obesity, offering a powerful tool for weight management and blood sugar control
These side effects may lessen over time

Product Attributes CAS # : 75921-69-6 Molecular Formula : C78H111N21O19 Sequence (AA) : Ac-Ser-Tyr-Ser-Nle-Glu-His-D-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2 Molecular Weight : 1646.85 g/mol PubChem CID : 16132139 Half-Life : ~30-60 minutes (extended pigmentation effect lasts weeks) Synonyms : Afamelanotide, MT-I, MT-1, NDP-MSH, Scenesse, [Nle4, D-Phe7]-alpha-MSH Type : Synthetic research peptide (alpha-MSH analog, MC1R agonist) Research Focus : Skin Pigmentation & Photoprotection, Melanocortin Signaling Scientific References Afamelanotide for prevention of phototoxicity in patients with erythropoietic protoporphyria Human RCT | Regulatory Afamelanotide and narrowband UV-B phototherapy for the treatment of vitiligo Human RCT Photoprotection by melanocortin 1 receptor agonists Animal | In vitro Afamelanotide: a melanocortin analogue for photoprotection Observational | Animal The melanocortin-1 receptor: red hair and beyond In vitro | Observational Melanocortin 1 receptor signaling and skin pigmentation In vitro | Animal Scenesse (afamelanotide) European Medicines Agency assessment report Regulatory | Human RCT Included In The Box Every product arrives in a premium, custom-designed PEPTIDE.Power box , engineered for convenience, hygiene, and safe storage in your refrigerator
